# Keynote Case Study: Genentech: Personalized Medicine Is Moving From Possibility To Platform.
By 

## Article Content
At Genentech, a member of the Roche Group, I addressed 550 executives in San Francisco and challenged them to think beyond breakthrough science toward the broader reinvention made possible by exponential genomics. The keynote, “Personalized Medicine in the Era of Exponential Genomics,” made the case that personalized medicine was moving from possibility to platform. Targeted therapies, genetic profiles, accelerating science and next generation healthcare were no longer separate initiatives. They were becoming one connected system. Six trends are shaping that shift. Exponential Genomics. Exploding genetic knowledge is accelerating discovery. Targeted Therapies. Treatments are being tailored to specific patient profiles. Biomarker-Driven Decisions. Better data is improving drug development and care. Faster Science Cycles. Knowledge and innovation are moving at unprecedented speed. Precision R&D. Research is becoming more personalized and data rich. Patient-Specific Care. Medicine is shifting toward the individual, not the average. The future of healthcare is individualized, data rich, science driven and fast. Personalized medicine is one of the themes I keep returning to on stage. The same pattern, science moving faster than the organizations built to apply it, keeps showing up across industries. You can browse more of that work in the case studies collection here.

---
Source: https://jimcarroll.com/2026/09/genentech-personalized-medicine-is-moving-from-possibility-to-platform/